BOSTON--(BUSINESS WIRE)--Axoft, a neurotechnology company, today launched and announced FDA Breakthrough Device designation for its brain-machine interface (BMI) to better treat neurological disorders. The company secured $8 million in capital to fund pre-clinical studies with the FDA and to scale up prototypes of its neural implants as soft as the brain. The seed round investment, led by The Engine, the venture firm spun out of MIT that invests in early-stage Tough Tech companies, included investors: Ab Initio Capital, Decent Capital, Alumni Ventures, Safar Partners, AIBasis, LiquidMetal VC, Taihill Venture, AMINO Capital, Blindspot Ventures and Mintz. The capital will also be used to expand the Axoft team.
The company was founded in 2021 by CEO Paul Le Floch and CTO Tianyang Ye, alongside Assistant Professor at Harvards School of Engineering and Applied Sciences Jia Liu, PhD. Axofts novel technology was born out of Dr. Lius work developing materials and designs of ultra-flexible nanoelectronics to mimic the mechanical and structural properties of the brain and was further researched by Le Floch while he was completing his PhD at Harvard in Mechanical Engineering and Material Sciences. The novel implants they developed are gliosis-free. In other words, the implants can reside in the central nervous system for the long term without harm. Axofts implants also exhibit electrical stability to track brain signals over the long term, and deliver an ultra-high density of sensors to maximize the information that can be exchanged between the brain and electronics.
Technology leaps in the semiconductor industry, development of novel advanced materials, chip design improvements, and progress in minimally invasive surgical approaches have opened opportunities for neurotechnology to be brought into the clinic and really help patients, said Paul Le Floch, Axoft co-founder and CEO. The pursuit of elevated quality of life, compounded by the increasing financial burden of neurological disorders due to an aging population are driving the demand for less invasive, more powerful neurological tools.
A recent report from the World Health Organization estimates that roughly nine million people die each year from neurological disorders, and that 1 in 3 people will develop a neurological disorder at some point in their life, making neurological disorders the leading cause of disability and the second leading cause of death globally.
Todays BMIs have not been developed to fully exploit the brains potential and are limited by the mechanical mismatch between electronics and brain tissues. Even ultra-thin wires are stiff, unlike brain tissue, and pose the danger of scarring and infection to the local brain region in which they are embedded. Axoft solves this issue by using a bioinspired material, malleable yet resilient, to make high density (large electrode count) probes with long-term stability and biocompatibility in the brain.
Axofts minimally invasive implants create a seamless interface with the nervous system, allowing ultra-high bandwidth and stable, single-neuron measurements. Whereas current implants have limited longevity and ability to track the same neurons in the brain over time, Axoft's implant material enables it to stay functional as the brain shifts or grows, minimizing the need for replacement and offering a long-term BMI to seamlessly connect the brain to electronics. Future applications in neuroprosthetics, like brain-control of man-made systems with large number of degrees of freedom, or real-time speech prediction, and in closed-loop neuromodulation for the treatment of movement disorders, memory loss and epilepsy, require communication with a large number of neurons in the brain. Currently approved systems are limited to 16-96 electrodes, which is not enough to enable these applications, and systems under development that have higher channel count typically sacrifice biocompatibility for bandwidth. Axofts implants are made of materials 10,000x softer than flexible electronics and can embed up to 1024 electrodes in a single strand thinner than a credit card.
Participation in the FDA Breakthrough Devices Program will speed the development, assessment and review of Axoft technology while preserving the standards for premarket approval and clearance for protection of public health. The company will introduce its technology in a staged approach, with the primary focus on improving quality of life; first addressing illnesses that have large patient populations that are underserved by current medical technology as well as diseases such as pediatric CP and epilepsy where patients undergo treatment for life-long conditions.
Axoft also announced The Engines General Partner Reed Sturtevant joined its Board of Directors. Sturtevant said: Axoft is taking a dramatic step forward from the fundamental brain-computer interface technologies and could be relevant for many conditions. This has the potential to be analogous to a pacemaker for the brain - a minimally invasive device that can listen, sense and stimulate a response. Imagine the impact this will have on neurodegenerative conditions like Parkinsons and Alzheimers diseases, seizures and movement disorders.
About AxoftAxofts bioinspired, scalable implant promotes long-term communication with the nervous system - transforming clinical outcomes, individual health, and the human experience. Uniquely engineered, Axofts implant mimics the soft tissues which surround it, while maintaining resilience against the harsh conditions of the brain. This seamless brain-machine interface means less damage to the patient, extended device stability and precise communication with a greater number of neurons. Axoft is redefining health with unparalleled access to neural code. Founder Paul Le Floch received the 2021 Forbes 30 under 30 distinction for Science. Find us online at: https://axoft.us/.
About The EngineThe Engine, spun out of MIT, invests in early-stage companies solving the worlds biggest problems through a convergence of breakthrough science, engineering, and leadership. We accelerate the path to market for Tough Tech companies through the combination of capital, infrastructure, and network. The Engine is headquartered in Cambridge, MA. For more information, visit http://www.engine.xyz.
Continue reading here:
- Opinion | The Fight for Your Kids' Brains Has Already Begun - The New York Times - September 9th, 2023 [September 9th, 2023]
- DEFENDING THE BRAIN | Duke Mag - Duke University - September 9th, 2023 [September 9th, 2023]
- The Innovations and Success of Elon Musk - OPP.Today - September 9th, 2023 [September 9th, 2023]
- Top Companies Using AI to Transform the Healthcare Industry ... - Cryptopolitan - September 9th, 2023 [September 9th, 2023]
- UN Warns Unregulated Neurotechnology Threatens 'Freedom of Thought' - Yahoo News - July 23rd, 2023 [July 23rd, 2023]
- I felt like there was someone in my head, and it wasn't me. - UNESCO - July 23rd, 2023 [July 23rd, 2023]
- Unraveling Connections Between the Brain and Gut - The Good Men Project - July 23rd, 2023 [July 23rd, 2023]
- Neurotechnology: what it is, applications - Iberdrola - February 10th, 2023 [February 10th, 2023]
- Forget Media Manipulation And Misinformation via TikTok And Twitter, Neurotechnology Heralds The New Battle For Our Brains - Forbes - February 10th, 2023 [February 10th, 2023]
- The Jacob Laboratory Translational Neurotechnology - January 2nd, 2023 [January 2nd, 2023]
- Massachusetts Institute Of Technology Experts Come Together In A Play Inspired By Advances In Neurotechnology - India Education Diary - January 2nd, 2023 [January 2nd, 2023]
- Neurotechnologies: The Next Technology Frontier | IEEE Brain - December 18th, 2022 [December 18th, 2022]
- Twelve Neurotechnology Startups to Present at 2022 Neurotech Leaders ... - November 19th, 2022 [November 19th, 2022]
- Research Experience for Undergraduates | Center for Neurotechnology - November 8th, 2022 [November 8th, 2022]
- Researcher combines AI and microelectronics to create neural implants that fight brain disorders - University of Toronto - October 19th, 2022 [October 19th, 2022]
- Global Contactless Biometrics Technology Market Size And Forecast | Aware Inc., Fingerprint Cards AB, Fujitsu Limited, Gemalto N.V., HID Global,... - October 19th, 2022 [October 19th, 2022]
- Facial Recognition Market Size and Share 2022 | Global Industry Analysis, Feasibility Study and Development Scope by 2032 | NEC Corporation (NEC)... - October 17th, 2022 [October 17th, 2022]
- Pitt scientists awarded $8 million for neurotechnology to restore arm and hand movements after strokes - University of Pittsburgh - October 15th, 2022 [October 15th, 2022]
- UN: Highlights from the 51st Session of the Human Rights Council - ARTICLE 19 - Article 19 - October 15th, 2022 [October 15th, 2022]
- PD Neurotechnology, a MedTech start-up for patients suffering from ... - October 8th, 2022 [October 8th, 2022]
- Brain ScienceConsciousness as the Property of Thought | Neurotech - VGR.com - October 6th, 2022 [October 6th, 2022]
- Facial Recognition Technology Market to witness a substantial growth owing to rising adoption of technology till 2032 | NEC Corporation, Aware,... - October 6th, 2022 [October 6th, 2022]
- ARC Future Fellowships awarded to Turner Institute researchers - Monash University - September 17th, 2022 [September 17th, 2022]
- Critics Picks: Cate Blanchett, Steven Spielberg Films Among the 15 Best of the Fall Festivals - Hollywood Reporter - September 17th, 2022 [September 17th, 2022]
- Stryker Launches Pulse Intelligent Delivery Platform at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting - Business Wire - September 17th, 2022 [September 17th, 2022]
- If separating conjoined twins results in death, which one should die? - Big Think - September 17th, 2022 [September 17th, 2022]
- Theater of Thought Review: Werner Herzog Crafts a Bracing Exploration of Neurotechnology and Consciousness - Hollywood Reporter - September 7th, 2022 [September 7th, 2022]
- Elon Musk seeks to expand his empire in the world of neurotechnology - Gearrice - September 7th, 2022 [September 7th, 2022]
- VoxNeuro Announces Collaboration with Boston University and Launch of Clinical Studies Focusing on Concussion and Alzheimers Disease - Yahoo Finance - September 7th, 2022 [September 7th, 2022]
- Tri-anim Health Services announces exclusive relationship to distribute BrainScope's breakthrough technology for mild head injury including... - September 7th, 2022 [September 7th, 2022]
- Interaxon Inc. (Muse) Highlights Myndlifts Preliminary Study and the Benefit of Partnerships for Digital Therapeutics Research - BioSpace - September 7th, 2022 [September 7th, 2022]
- Elon Musk and Neuralink executive Shivon Zilis reportedly conceived twins via IVF - The Independent - August 29th, 2022 [August 29th, 2022]
- Biometric Wearable Market Research Insights with Trends, Competitive Analysis, Opportunities, Forecast 2022 to 2030 Muleskinner - Muleskinner - August 29th, 2022 [August 29th, 2022]
- Neurotechnology - the future of the legal profession? - Lexology - August 25th, 2022 [August 25th, 2022]
- Future criminals could be monitored by chips in their brains, experts claim... - The US Sun - August 25th, 2022 [August 25th, 2022]
- Stryker to participate in the 2022 Wells Fargo Securities Healthcare Conference - GuruFocus.com - August 25th, 2022 [August 25th, 2022]
- Investing in Brain Research and Neuroengineering - University of Houston - August 2nd, 2022 [August 2nd, 2022]
- Hamilton-based Zentrela working to understand the cannabis experience - Hamilton Spectator - August 2nd, 2022 [August 2nd, 2022]
- IntualityAI may be Able to Provide Psychotherapy for Robots in Future - AZoRobotics - August 2nd, 2022 [August 2nd, 2022]
- Coconuts, Corporations: On Vauhini Vara's The Immortal King Rao - lareviewofbooks - August 2nd, 2022 [August 2nd, 2022]
- MindMaze Enters New Strategic Partnership with Alfa Romeo F1 Team ORLEN to Advance Technologies for Brain Health, Safety, and Performance - Yahoo... - July 13th, 2022 [July 13th, 2022]
- MindMaze Receives Recognition as one of Switzerland's Best Managed Companies - Business Wire - July 13th, 2022 [July 13th, 2022]
- OpenBCI and Varjo Partner to Bring Neurotechnology to Spatial Computing - July 11th, 2022 [July 11th, 2022]
- Three top technologies taking healthcare by storm - Kalkine Media - July 11th, 2022 [July 11th, 2022]
- It is time to leverage technology to correct the challenges people have with their minds: Antano Solar, CE.. - ETHealthWorld - July 11th, 2022 [July 11th, 2022]
- Elon Musk Secretly Fathered Twins With His Company's Executive: Report - KFI AM 640 - July 11th, 2022 [July 11th, 2022]
- Stryker to host conference call on July 26, 2022 - GuruFocus.com - July 11th, 2022 [July 11th, 2022]
- Neurotechnology Announces MOSIP Integration and Support in MegaMatcher SDK and ABIS - PR Newswire - June 15th, 2022 [June 15th, 2022]
- Musk's Twitter $44 Billion Bid Includes Financier Close to Russia - Report By Investing.com - Investing.com - June 15th, 2022 [June 15th, 2022]
- Stryker Strengthens Its R&D Capabilities with Advanced Global Technology Center - Press Trust of India - Press Trust of India - June 9th, 2022 [June 9th, 2022]
- Cuba is the only nation with a governmental science and technology program on the brain - Granma English - June 9th, 2022 [June 9th, 2022]
- 3 Disruptive Tech Stocks to Go All In on Now - InvestorPlace - June 9th, 2022 [June 9th, 2022]
- OpenBCI and Varjo Partner to Bring Neurotechnology to Spatial Computing - PR Newswire - June 5th, 2022 [June 5th, 2022]
- 3D Reconstruction Technology Market Size, Scope and Forecast | 3D Reconstruction, Eos Systems Inc., Everest Innovation Technology, Microsoft, NAVVIS,... - June 5th, 2022 [June 5th, 2022]
- Fingerprint Biometrics in the VAR Market to Eyewitness Massive Growth by 2031 The Greater Binghamton Business Journal - The Greater Binghamton... - June 5th, 2022 [June 5th, 2022]
- Horrors of Elon Musks Neuralink REVEALED including brain hacking technology and animal deaths... - The Scottish Sun - May 25th, 2022 [May 25th, 2022]
- Stryker Co. (NYSE:SYK) Receives Consensus Rating of Buy from Brokerages - Defense World - May 25th, 2022 [May 25th, 2022]
- Evon Medics, LLC Has Been Awarded $2.8 Million Grant for the Development and Evaluation of its Mobile Health Platform for Remote Management of... - May 11th, 2022 [May 11th, 2022]
- Mobile Biometrics Market Analysis by Size, Business Strategies, Share, Growth, Trends, Revenue, Competitive Landscape and Developments Forecast by... - May 11th, 2022 [May 11th, 2022]
- Dubai on the Brain: NeuroVigil's Philip Low Assembles ... - May 6th, 2022 [May 6th, 2022]
- Research Associate: Participatory Research and Communications Officer job with KINGS COLLEGE LONDON | 292429 - Times Higher Education - May 6th, 2022 [May 6th, 2022]
- Face Recognition Software Market 2022: Size, Industry Share, Approaches, and Forecast By 2028, (Idemia (FR), Aware (US), Leidos (US), BioID (DE)) ... - May 6th, 2022 [May 6th, 2022]
- Stocktake: Investors wary on Musk's Twitter deal - The Irish Times - May 6th, 2022 [May 6th, 2022]
- Hydrocolloid Dressing Market Competitive Landscape Analysis With Forecast by 2027 - BioSpace - May 6th, 2022 [May 6th, 2022]
- Futuristics Overview of Neural Control Market: Industry Insights and Forecast 2022-2028 by MIT, Hebrew university, Haier, Neurotechnology,,, and more... - May 3rd, 2022 [May 3rd, 2022]
- Brain Computer Interface (BCI) Market Poised to Garner a Valuation of USD 5.48 Billion by 2030, Growing at a 14.72% CAGR - Report by Market Research... - May 3rd, 2022 [May 3rd, 2022]
- Stryker's InSpace subacromial balloon spacer two-year, Level 1 randomized controlled clinical study published in the Journal of Bone and Joint Surgery... - May 3rd, 2022 [May 3rd, 2022]
- Stryker to participate in the Bank of America Securities 2022 Health Care Conference - Benzinga - Benzinga - May 3rd, 2022 [May 3rd, 2022]
- Earnings week 2: Supply chain shortages slowed ResMed, other medtechs from meeting demand - MedTech Dive - May 3rd, 2022 [May 3rd, 2022]
- Mind-reading technology Are we ready for it? - Freethink - April 25th, 2022 [April 25th, 2022]
- The brain implant that can translate your thoughts into text - SBS News - April 15th, 2022 [April 15th, 2022]
- Stryker says 88 jobs to be eliminated in May, part of previously announced layoff schedule - The Ledger - April 15th, 2022 [April 15th, 2022]
- Moon Rabbit Collaborates with Foresight Institute to Speed Up Life Extension Research - CryptoNewsZ - April 4th, 2022 [April 4th, 2022]
- Cybin Announces Initiation of Kernel Flow Feasibility Study Measuring Psychedelic Effects on the Brain - Business Wire - April 4th, 2022 [April 4th, 2022]
- Restoring touch through electrodes implanted in the human brain will require engineering around a sensory lag - The Conversation Indonesia - March 31st, 2022 [March 31st, 2022]
- Carry On: From ketamine-assisted therapy to neurofeedback training, here's how to take a trip without leaving B.C. - BCBusiness - March 31st, 2022 [March 31st, 2022]
- Omniscient Neurotechnologys Quicktome Platform Wins 2022 ... - March 18th, 2022 [March 18th, 2022]
- Applied neuroscience needs a task force to craft effective governance - STAT - March 18th, 2022 [March 18th, 2022]
- It Can Take Weeks for Some Patients With Severe COVID to Recover Consciousness - HealthDay News - March 18th, 2022 [March 18th, 2022]
- Global Neural Control Market 2022 Outlook and COVID-19 Impact Prediction 2028 MIT, Hebrew university, Haier, Neurotechnology The Bite - The Bite - March 18th, 2022 [March 18th, 2022]